Woo-Jeong Jeong

发表

WDR76 mediates obesity and hepatic steatosis via HRas destabilization

Kang-Yell Choi, Jong-Chan Park, Woo-Jeong Jeong, 2019, Scientific Reports.

Retinoic-acid-mediated HRas stabilization induces neuronal differentiation of neural stem cells during brain development

Kang-Yell Choi, D. Min, Mi-Yeon Kim, 2016, Journal of Cell Science.

β‐Catenin‐RAS interaction serves as a molecular switch for RAS degradation via GSK3β

Weontae Lee, Kang-Yell Choi, G. Han, 2018, EMBO reports.

Ras Stabilization Through Aberrant Activation of Wnt/β-Catenin Signaling Promotes Intestinal Tumorigenesis

Hoguen Kim, Jong-Bok Yoon, Kang-Yell Choi, 2012, Science Signaling.

YAP1 and TAZ Activates mTORC1 Pathway by Regulating Amino Acid Transporters in hepatocellular carcinoma

Park, G. Mills, Ju-Seog Lee, 2016 .

Akt is involved in the inhibition of cell proliferation by EGF

S. Jeon, Kang-Yell Choi, Jaeyoung Cho, 2007, Experimental & Molecular Medicine.

WDR76 degrades RAS and suppresses cancer stem cell activation in colorectal cancer

Kang-Yell Choi, D. Min, Jong-Chan Park, 2019, Cell Communication and Signaling.

WDR76 is a RAS binding protein that functions as a tumor suppressor via RAS degradation

Y. N. Park, S. Jeon, Kang-Yell Choi, 2019, Nature Communications.

H-Ras is degraded by Wnt/β-catenin signaling via β-TrCP-mediated polyubiquitylation

Hoguen Kim, Jong-Bok Yoon, S. Jeon, 2009, Journal of Cell Science.

Axin Inhibits Extracellular Signal-regulated Kinase Pathway by Ras Degradation via β-Catenin*

Y. Surh, S. Jeon, Kang-Yell Choi, 2007, Journal of Biological Chemistry.

A small molecule approach to degrade RAS with EGFR repression is a potential therapy for KRAS mutation-driven colorectal cancer resistance to cetuximab

Kang-Yell Choi, G. Han, D. Min, 2018, Experimental & Molecular Medicine.

Interaction between Wnt/β-catenin and RAS-ERK pathways and an anti-cancer strategy via degradations of β-catenin and RAS by targeting the Wnt/β-catenin pathway

Woo-Jeong Jeong, Kang-Yell Choi, Kang-Yell Choi, 2018, npj Precision Oncology.

Small-molecule binding of the axin RGS domain promotes β-catenin and Ras degradation.

Mi-Yeon Kim, Weontae Lee, Woo-Jeong Jeong, 2016, Nature chemical biology.

Role of oncogenic K-Ras in cancer stem cell activation by aberrant Wnt/β-catenin signaling.

Kang-Yell Choi, D. Min, T. Kim, 2014, Journal of the National Cancer Institute.

Sur8/Shoc2 promotes cell motility and metastasis through activation of Ras-PI3K signaling

S. Jeon, Kang-Yell Choi, D. Min, 2015, Oncotarget.

Strategies to overcome resistance to epidermal growth factor receptor monoclonal antibody therapy in metastatic colorectal cancer.

Kang-Yell Choi, Woo-Jeong Jeong, Pu-Hyeon Cha, 2014, World journal of gastroenterology.

Sur8 mediates tumorigenesis and metastasis in colorectal cancer

Kang-Yell Choi, Jong-Chan Park, Young-Mi Lee, 2016, Experimental & Molecular Medicine.

WDR76 degrades RAS and suppresses cancer stem cell activation in colorectal cancer

Kang-Yell Choi, D. Min, Jong-Chan Park, 2019, Cell Communication and Signaling.

A small molecule approach to degrade RAS with EGFR repression is a potential therapy for KRAS mutation-driven colorectal cancer resistance to cetuximab

Kang-Yell Choi, G. Han, D. Min, 2018, Experimental & Molecular Medicine.

NM23H2 inhibits EGF- and Ras-induced proliferation of NIH3T3 cells by blocking the ERK pathway.

Kang-Yell Choi, Mi-Young Lee, Jong-Won Oh, 2009, Cancer letters.

Stabilization of Sur8 via PKCα/δ degradation promotes transformation and migration of colorectal cancer cells

Kang-Yell Choi, D. Min, Woo-Jeong Jeong, 2017, Oncotarget.

K-Ras stabilization by estrogen via PKCδ is involved in endometrial tumorigenesis

Kang-Yell Choi, D. Min, Jong-Chan Park, 2015, Oncotarget.